Displaying items by tag: Department of Neurology

The drug inhibits the activity of a kinase enzyme called LRRK2, and it showed no pathology in rat lungs, kidneys or livers.
Robin Lorenz, M.D., Ph.D. and Anthony Nicholas, M.D., Ph.D., were honored with the UAB President’s Award for Excellence in Teaching. 
The University of Alabama Board of Trustees approved the creation of the Personalized Medicine Institute, the Institute for Informatics and the UAB-HudsonAlpha Center for Genomic Medicine.
Scott Plutchak's diagnosis of transverse myelitis exposed him to a quality of medical communication not often encountered.
Can smell tests reveal brain changes that are precursors to Parkinson's? Research podcast with David Standaert, M.D., Ph.D.
UAB Neurology study adds to evidence that massive, second-wave reaction kills nerve cells.
The finding may help to avert more of the bleeds and blood clots that come when a patient’s starting dose misses the drug’s narrow safety window.
He has been an active member of the American Parkinson Disease Association Scientific Advisory Board since May 2001 and is the board’s fourth chairman since the organization’s founding in 1961.
Page 8 of 9